Literature DB >> 2863748

Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes.

K Nishikura, S Goldflam, G A Vuocolo.   

Abstract

We investigated the expression of the cloned human c-myc gene in Xenopus laevis oocytes microinjected with different recombinants. We found that microinjected plasmid DNA carrying an intact human c-myc gene directs efficient and faithful transcription from its own two promoters in X. laevis oocytes. This active transcription was unaffected by the presence of previously identified enhancing elements such as simian virus 72-base pair repeats or mouse immunoglobulin heavy-chain gene enhancer sequences in the construct in cis. This suggests that all necessary DNA sequences for accurate and faithful transcription recognized by the transcription machinery of the frog oocyte are self-contained. In addition, we have found that human c-myc transcripts synthesized in oocytes are properly polyadenylated at either one of two sites and also that the transcripts are spliced correctly but with low efficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863748      PMCID: PMC366874          DOI: 10.1128/mcb.5.6.1434-1441.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.

Authors:  S D Gillies; S L Morrison; V T Oi; S Tonegawa
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

2.  A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes.

Authors:  J Banerji; L Olson; W Schaffner
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

3.  Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene.

Authors:  P H Hamlyn; T H Rabbitts
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

4.  Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient.

Authors:  R Dalla-Favera; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

5.  Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.

Authors:  J M Adams; S Gerondakis; E Webb; L M Corcoran; S Cory
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Post-transcriptional processing of simian virus 40 late transcripts in injected frog oocytes.

Authors:  M P Wickens; J B Gurdon
Journal:  J Mol Biol       Date:  1983-01-05       Impact factor: 5.469

7.  Transcription in vivo from SV40 early promoter deletion mutants without repression by large T antigen.

Authors:  M Fromm; P Berg
Journal:  J Mol Appl Genet       Date:  1983

8.  Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas.

Authors:  L W Stanton; R Watt; K B Marcu
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

9.  Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.

Authors:  K Nishikura; A ar-Rushdi; J Erikson; R Watt; G Rovera; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Nucleotide sequence of cloned cDNA of human c-myc oncogene.

Authors:  R Watt; L W Stanton; K B Marcu; R C Gallo; C M Croce; G Rovera
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

View more
  10 in total

1.  A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor.

Authors:  E H Postel; S E Mango; S J Flint
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

2.  Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes.

Authors:  H E Broome; J C Reed; E P Godillot; R G Hoover
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

3.  A combination of RNase H and S1 nuclease circumvents an artefact inherent to conventional S1 analysis of RNA splicing.

Authors:  S S Sisodia; D W Cleveland; B Sollner-Webb
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

4.  Sequences involved in accurate and efficient transcription of human c-myc genes microinjected into frog oocytes.

Authors:  K Nishikura
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

5.  pBR322 DNA inhibits simian virus 40 gene expression in Xenopus laevis oocytes.

Authors:  T Michaeli; C Prives
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

6.  Analysis of polyadenylation site usage of the c-myc oncogene.

Authors:  I A Laird-Offringa; P Elfferich; H J Knaken; J de Ruiter; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

7.  Delimitation and characterization of cis-acting DNA sequences required for the regulated expression and transcriptional control of the chicken skeletal alpha-actin gene.

Authors:  D J Bergsma; J M Grichnik; L M Gossett; R J Schwartz
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

8.  Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered.

Authors:  S N Finver; K Nishikura; L R Finger; F G Haluska; J Finan; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  Characterization of rat c-myc and adjacent regions.

Authors:  K Hayashi; R Makino; H Kawamura; A Arisawa; K Yoneda
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

10.  Regulation of C-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells.

Authors:  S D Gowda; R D Koler; G C Bagby
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.